Immunovant, Inc. IMVT Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s non-cash lease expense?
- Immunovant, Inc. (IMVT) reported non-cash lease expense of $26K in Q1 2026.
- How has Immunovant, Inc.'s non-cash lease expense changed year-over-year?
- Immunovant, Inc.'s non-cash lease expense increased by 18.2% year-over-year, from $22K to $26K.
- What is the long-term trend for Immunovant, Inc.'s non-cash lease expense?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s non-cash lease expense has grown at a -45.3% compound annual growth rate (CAGR), from $1.11M to $99K.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.